US FDA Cites Concerns with Alkermes Addiction Drug

WASHINGTON, Sept 14 (Reuters) - Alkermes Inc’s (ALKS.O) drug to help wean alcoholics from drinking appears to also help treat people addicted to certain painkillers based on a small, limited study, U.S. regulatory staff said in documents released on Tuesday.

MORE ON THIS TOPIC